| Tuesday | June 5, 2018 | Special Conference Committee Board Room 2 | Agenda | |
| Wednesday | June 20, 2018 9:30 a.m. | Inspection Special Conference Committee Board Room 2 | ||
| Wednesday | June 20, 2018 1:00 p.m. | Ad Hoc Committee for Routine Pharmacy Inspection Process Board Room 2 | ||
| Thursday | June 21, 2018 9:00 a.m. | Public Hearing to Schedule Certain Chemicals in Schedule I and to conform to DEA scheduling | Agenda | |
| Thursday | June 21, 2018 | Full Board Meeting Board Room 2 | ||
| Thursday | June 21, 2018 | Formal Hearing Board Room 2 |
Tuesday, June 5, 2018
Virginia Board of Pharmacy Meetings for June 2018
Washington Pharmacy Quality Assurance Commission Meetings Set for June 7-8, 2018 Agenda Attached
June 8, 2018
Department of Health
310 Israel Rd S..E. Rm 152/153 Tumwater | Directions |
Business Meeting
In person or by webinar – Register here
Webinar ID# 586-575-115
| Agenda (PDF) |
June 7, 2018
Department of Health
310 Israel Rd S..E. Rm 152/153 Tumwater | Directions |
Rule Rewrite
In person or by webinar – Register here
Webinar ID# 586-575-115
| Agenda (PDF) |
Wyoming Board of Pharmacy Meeting June 20-21, 2018
June 20-21, 2018
| Sheridan | Begins at 1:00 PM Wednesday, June 20 224 S Main St, Sheridan, WY 82801 |
New Hampshire Board of Pharmacy Meeting Scheduled for June 20, 2018
- June 20, 2018 at 8:30 a.m. at MCPHS Campus,
1260 Elm Street, Room 202, Manchester, NH(Agenda Will Be Posted Friday, June 15)
Nevada Board of Pharmacy Meeting Scheduled for June 6-7, 2018 Agenda and Attachments
| Date | Location | Agenda | Minutes | Attachments |
|---|---|---|---|---|
Public Hearing R131-17, R013-18 & R047-18
| ||||
06/07/2018
09:00 AM
|  - Hyatt Place 1790 E Plumb Ln - Reno, NV |  | ||
Board Meeting (Two Days 6/6/2018 - 6/7/2018)
| ||||
06/06/2018
09:00 AM
| - Hyatt Place 1790 E Plumb Ln - Reno, NV | | | |
Missouri Board of Pharmacy Sterile Compounding Sub-Committee Conference Call June 1, 2018 3:00 p.m
Meeting Notice
Missouri Board of Pharmacy
Sterile Compounding Sub-Committee
Conference Call
June 1, 2018 3:00 p.m.
Division of Professional Registration
3605 Missouri Boulevard
Jefferson City, MO 65109
2018-06-01 (Sterile Compounding Sub-Committee)
2018-06-01 (Sterile Compounding Sub-Committee)
COMING TO A CITY NEAR YOU!
MISSOURI BOARD OF PHARMACY 2018 PATIENT SAFETY & COMPLIANCE SEMINAR
WHERE:
St. Louis College of Pharmacy
4588 Parkview Place
St. Louis, MO 63110
4588 Parkview Place
St. Louis, MO 63110
DATES: June 21, 2018 (St. Louis)
TOPICS:
- Enhancing Patient Safety
- BNDD Update
- Compliance: What You Need to Know
- Inspector Roundtable/Q&A
- Board Updates
TIME: 12:30 p.m. to 4:30 p.m.
Register online at http://www.planetReg.com/E59143826229857.
Registration is FREE but space is limited. Board approved for 3.5 Missouri pharmacist continuing education hours.
Registration is FREE but space is limited. Board approved for 3.5 Missouri pharmacist continuing education hours.
Louisiana Board of Pharmacy Legislative Proposals Effective August 1, 2018
2018-K ~ Amends the PMP Law to grant access to state epidemiologists with Dept. of Health.
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Draft #3 approved for filing by the Board.
02-26-2018 - Incorporated in SB 109; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 232 (SB 109).
2018-J ~ Amends the pharmacist licensure requirements in the Pharmacy Practice Act.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 131; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 31 (SB 131).
2018-H ~ Amends the statutory definition of "drugs of concern" in the Prescription Monitoring Program (PMP) to facilitate the reporting of prescriptions for naloxone.
02-07-2018 - Committee reviewed Draft #1 and requested a minor amendment, then voted to recommend the approval of Draft #2 to the Board.
02-21-2018 - Draft #2 approved for filing by the Board.
02-26-2018 - Incorporated in SB 110; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 146 (SB 110).
2018-G ~ Amends the Prescription Monitoring Program (PMP) Law to change the reporting frequency for dispensers of controlled substances and drugs of concern.
02-07-2018 - Committee voted to defer action on Draft #1 until a later date.
2018-F ~ Amends the Prescription Monitoring Program (PMP) Law to authorize designated representatives of the Medicaid program to access audit trail information for providers caring for Medicaid recipients.
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Board declined to approve Draft #3 for filing by the Board.
2018-E ~ Amends the Controlled Substances Law to permit the partial filling of prescriptions for all medications listed in Schedule II, consistent with federal legislation adopted in 2016.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 134; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 32 (SB 134).
2018-D ~ Amends the Pharmacy Practice Act to allow the Board to waive the license renewal fee for spouses of pharmacists or technicians serving in active duty military.
11-15-2017 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 150: prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 63 (HB 150).
2018-C ~ Amends the statutory definition of "approved college of pharmacy" in the Pharmacy Practice Act to remove a specifically titled reference book of foreign pharmacy schools.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 151; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 64 (HB 151).
2018-B ~ Amends the Controlled Substances Law to define 'third-party logistics provider', identify such an entity as one of the entities requiring a Controlled Dangerous Substance (CDS) license to transact business with controlled substances, and to set the fee for CDS licenss issued to such entities.
09-28-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
11-15-2017 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 45; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 186 (HB 45).
2018-A ~ Amends the Controlled Substances Law to add additional substances to Schedule I and removes a substance from Schedule II, consistent with DEA scheduling actions since the last state legislative session.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 153; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 119 (HB 153).
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Draft #3 approved for filing by the Board.
02-26-2018 - Incorporated in SB 109; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 232 (SB 109).
2018-J ~ Amends the pharmacist licensure requirements in the Pharmacy Practice Act.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 131; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 31 (SB 131).
2018-H ~ Amends the statutory definition of "drugs of concern" in the Prescription Monitoring Program (PMP) to facilitate the reporting of prescriptions for naloxone.
02-07-2018 - Committee reviewed Draft #1 and requested a minor amendment, then voted to recommend the approval of Draft #2 to the Board.
02-21-2018 - Draft #2 approved for filing by the Board.
02-26-2018 - Incorporated in SB 110; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 146 (SB 110).
2018-G ~ Amends the Prescription Monitoring Program (PMP) Law to change the reporting frequency for dispensers of controlled substances and drugs of concern.
02-07-2018 - Committee voted to defer action on Draft #1 until a later date.
2018-F ~ Amends the Prescription Monitoring Program (PMP) Law to authorize designated representatives of the Medicaid program to access audit trail information for providers caring for Medicaid recipients.
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Board declined to approve Draft #3 for filing by the Board.
2018-E ~ Amends the Controlled Substances Law to permit the partial filling of prescriptions for all medications listed in Schedule II, consistent with federal legislation adopted in 2016.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 134; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 32 (SB 134).
2018-D ~ Amends the Pharmacy Practice Act to allow the Board to waive the license renewal fee for spouses of pharmacists or technicians serving in active duty military.
11-15-2017 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 150: prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 63 (HB 150).
2018-C ~ Amends the statutory definition of "approved college of pharmacy" in the Pharmacy Practice Act to remove a specifically titled reference book of foreign pharmacy schools.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 151; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 64 (HB 151).
2018-B ~ Amends the Controlled Substances Law to define 'third-party logistics provider', identify such an entity as one of the entities requiring a Controlled Dangerous Substance (CDS) license to transact business with controlled substances, and to set the fee for CDS licenss issued to such entities.
09-28-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
11-15-2017 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 45; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 186 (HB 45).
2018-A ~ Amends the Controlled Substances Law to add additional substances to Schedule I and removes a substance from Schedule II, consistent with DEA scheduling actions since the last state legislative session.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 153; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 119 (HB 153).
Subscribe to:
Posts (Atom)